Barbara W. Bodem

CIK: 0001713893

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

BMRN

BIOMARIN PHARMACEUTICAL INC

Director

OPCH

Option Care Health, Inc.

Director

ENOV

Enovis CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
Jun 2, 2026
Award(A)
Direct
7.5K shares-
OPCH
Option Care Health, Inc.
May 20, 2026
Award(A)
Direct
9K shares-
ENOV
Enovis CORP
May 19, 2026
Award(A)
Direct
9.3K shares-
ENOV
Enovis CORP
May 21, 2025
Award(A)
Direct
6.6K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
May 20, 2025
Award(A)
Direct
6.7K shares-
OPCH
Option Care Health, Inc.
May 14, 2025
Award(A)
Direct
5K shares-

		Type	Shares	Price		Ownership
Jun 2, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	7,490	-	$0	Direct
May 20, 2026	OPCH Option Care Health, Inc.	Award(A)	8,997	-	$0	Direct
May 19, 2026	ENOV Enovis CORP	Award(A)	9,346	-	$0	Direct
May 21, 2025	ENOV Enovis CORP	Award(A)	6,598	-	-	Direct
May 20, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	6,650	-	-	Direct
May 14, 2025	OPCH Option Care Health, Inc.	Award(A)	5,034	-	-	Direct

1-6 of 6 transactions

About Bodem Barbara W.

Bodem Barbara W. (SEC CIK 0001713893) files insider reports with the SEC as Director of BIOMARIN PHARMACEUTICAL INC (BMRN), Director of Option Care Health, Inc. (OPCH) and Director of Enovis CORP (ENOV).

Signal8 holds 6 ownership filings by Bodem Barbara W., all Form 4s, filed between May 19, 2025 and Jun 4, 2026. Those filings report 6 transactions, from May 14, 2025 to Jun 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bodem Barbara W.'s filings is in SAN RAFAEL, CA.

Recent filings by Bodem Barbara W.

Jun 2, 2026: Grant or award of BMRN shares (Form 4, code A).
May 20, 2026: Grant or award of OPCH shares (Form 4, code A).
May 19, 2026: Grant or award of ENOV shares (Form 4, code A).
May 21, 2025: Grant or award of ENOV shares (Form 4, code A).
May 20, 2025: Grant or award of BMRN shares (Form 4, code A).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R, EVP, Chief R&D Officer
Plenge Robert M, Director
Davis George Eric, EVP, Chief Legal Officer
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director

How to read Form 4 transaction codes